Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, especially for cancers where remedy solutions remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/sec-delays-decision-on-ether-etf-options-extending-review-until-may/